Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neurotech International Ltd
NTICurrent price
0.071 AUD
+0.000000000074 AUD (+0.00%)
Last closed
0.07 AUD
Company
www.neurotechinternational.com
ISIN
AU000000NTI9
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
71 292 457 AUD
Yield for 12 month
+4.41 %
1Y
3Y
5Y
10Y
15Y
NTI
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia. Address: 145 Stirling Highway, Nedlands, WA, Australia, 6009
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+1 938 AUD
Last Year
+5 881 AUD
Current Quarter
+450 AUD
Last Quarter
+1 487 AUD
Current Year
-569 870 AUD
Last Year
+4 160 AUD
Current Quarter
-319 110 AUD
Last Quarter
-936 631 AUD
Key Figures NTI
1 year
3 years
5 years
10 years
EBITDA
-5 157 625 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.29 %
PEG Ratio
–
Return On Equity TTM
-63.92 %
Wall Street Target Price
–
Revenue TTM
3 135 271 AUD
Book Value
0.012 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
167.5 %
Dividend Yield
–
Gross Profit TTM
1 178 675 AUD
Earnings per share
-0.0099 AUD
Diluted Eps TTM
-0.0099 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-159.54 %
Dividend Analytics NTI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
8:7
Payout Ratio
–
Last Split Date
01.02.2019
Dividend Date
–
Stock Valuation NTI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
30364.6057
Price Sales TTM
22.7389
Enterprise Value EBITDA
-6.7445
Price Book MRQ
5.9865
Financials NTI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NTI
For 52 weeks
0.051 AUD
0.12 AUD
50 Day MA
0.072 AUD
Shares Short Prior Month
–
200 Day MA
0.079 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart